Table 3.

Multivariable regression analysis on the need for a permanent pacemaker and on paravalvular leakage

	Pacemaker implantation OR (95% CI)	p-value
Type of THV used
Evolut R	1.00 (reference)	–
CoreValve	2.79 (1.31–5.94)	0.008
Evolut PRO	1.18 (0.52–2.71)	0.69
Male gender	0.71 (0.36–1.42)	0.33
RBBB at baseline	14.44 (5.59–37.28)	<0.005
LAFB at baseline	1.28 (0.46–3.61)	0.64
AV1B at baseline	3.36 (1.64–6.87)	0.001
Mean depth of implantation (mm)	1.21 (1.09–1.34)	<0.005
Annular sizing ratio	0.17 (0.002–11.700)	0.41
Peripheral artery disease	1.70 (0.91–3.18)	0.098
	Moderate or severe PVL OR (95% CI)	p‑value
Type of THV used
Evolut R	1.00 (reference)	–
CoreValve	2.06 (0.79–5.39)	0.14
Evolut PRO	0.53 (0.16–1.77)	0.30
Bicuspid valve (functional)	1.51 (0.46–4.96)	0.49
Annular sizing ratio	0.02 (0.000–5.410)	0.18
Post-dilatation	5.56 (2.23–13.86)	<0.005

Variables are shown as OR (95% CI)

OR odds ratio, CI confidence interval, THV transcatheter heart valve, RBBB right bundle branch block, LAFB left anterior fascicular block, AV1B first-degree atrioventricular block, PVL paravalvular leakage